Close Menu

NEW YORK – Oxford Immunotec reported today an 18 percent year-over-year increase in second quarter revenues as the company beat analyst estimates on the top and bottom lines.

For the three months ended June 30, 2019, Oxford Immunotec logged total revenues of $19.6 million compared to $16.7 million in the year-ago period. On average, analysts had expected revenues of $19.4 million.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.